| Market Capitalization (Millions $) |
- |
| Shares
Outstanding (Millions) |
40 |
| Employees |
500 |
| Revenues (TTM) (Millions $) |
240 |
| Net Income (TTM) (Millions $) |
-38 |
| Cash Flow (TTM) (Millions $) |
-6 |
| Capital Exp. (TTM) (Millions $) |
5 |
Business Description
Cardiovascular Systems Inc. (CSI) is a company that provides advanced solutions for the treatment of vascular and coronary diseases. The company specializes in developing, manufacturing, and marketing innovative medical devices that can be used by healthcare professionals to diagnose and treat patients with arterial diseases.
CSI was founded in 1989 by Dr. David L. Martin, who is a pioneer in the field of vascular intervention. The company is based in St. Paul, Minnesota, and operates in more than 60 countries worldwide. It has a team of over 1,300 professionals, including engineers, sales representatives, and clinical specialists, who are dedicated to improving the lives of patients suffering from cardiovascular diseases.
The company's flagship product is its Diamondback 360e Orbital Atherectomy System, which is a minimally invasive device used for the treatment of peripheral arterial disease (PAD). The device is used to remove calcium and plaque build-up from arteries, thereby restoring blood flow and reducing the risk of amputation. The device is designed to be easy to use, safe, and effective, and it has been used to treat more than 500,000 patients across the world.
In addition to the Diamondback 360e Orbital Atherectomy System, CSI also offers a range of other products and services, including the Stealth 360e Orbital Atherectomy System, which is used for the treatment of coronary artery disease (CAD), the ViperWiree Advance Coronary Guide Wire, and the Vascadee Vascular Closure System.
CSI is committed to advancing the science of vascular intervention through clinical research and development. The company has invested more than $250 million in research and development, and it has published more than 200 clinical publications in leading medical journals. CSI has also received numerous awards and recognitions for its technological innovations, including being named one of Forbes' Top 100 Small Companies in America in 2014.
Overall, Cardiovascular Systems Inc. is a pioneering medical device company that is dedicated to advancing the treatment of vascular and coronary diseases. With its innovative technology and commitment to clinical research and development, CSI is helping to improve the lives of patients around the world.
Company Address: 1225 Old Highway 8 Northwest St. Paul 55112 MN
Company Phone Number: 259-1600 Stock Exchange / Ticker: NASDAQ CSII
|
%
0.57% 